trending Market Intelligence /marketintelligence/en/news-insights/trending/jtl01cyg1xqyyiqzhaxdaw2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us
In This List

Immune Pharmaceuticals director resigns

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

Immune Pharmaceuticals director resigns

Immune Pharmaceuticals Inc. said Cameron Durrant resigned as a director.

Englewood Cliffs, N.J.-based Immune Pharmaceuticals develops treatments for immunologic and inflammatory diseases.